MedPath

Trial of Protein Supplement on Vertebral Fusion in Posterior Spine Fusion Surgery

Not Applicable
Completed
Conditions
Spine Surgery
Interventions
Drug: protein supplement
Other: Carbo Mass
Registration Number
NCT04091841
Lead Sponsor
Shahid Beheshti University
Brief Summary

Receiving protein can affect the bone formation and maintenance by providing a structural matrix of the bone, optimizing the level of IGF-1, increasing intestinal calcium absorption, transferring phosphorous, and improving muscle strength.Therefore, protein may be effective on vertebral fusion by such mechanisms. In this trial patients undergoing elective posterior spine fusion surgery are divided into two groups of intervention or control.

Detailed Description

A randomized, double blind, controlled trial will be conducted in patients undergoing elective posterior spine fusion surgery in Tehran, Iran. After a full review of the inclusion and exclusion criteria and explanation of the risks and benefits of the study, written consent form will be completed. The participants are 80 eligible posterior spine fusion surgery patients, aged ≥ 18 years. Intervention patients will be received 36 grams of protein supplement along with diet containing 1.2 g/kg/day of protein for 30 days after surgery and control patients will be received Carbo Mass along with diet containing 1.2 g/kg/day of protein 30 days after surgery. Patients will be evaluated for occurrence of vertebral fusion and enhanced recovery after 3 months surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria
  • Allergy or intolerance to protein or maltodextrine supplement
  • Unwillingness to continue cooperation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
protein supplementprotein supplementIntervention patients will be received protein diet (1.2 g/kg/day) and protein supplement (36 g/day) for 1 month after surgery.
Carbo MassCarbo MassControl patients will be received protein diet (1.2 g/kg/day) and Carbo Mass for 1 month after surgery.
Primary Outcome Measures
NameTimeMethod
Rate of vertebral fusion in CT scan6 months after surgery

Rate of formation of a solid bony Union in CT scan

Secondary Outcome Measures
NameTimeMethod
Rate of wound healingDischarge, 15 days and 1 month after surgery

Rate of wound healing, the sutures of the surgery, inspected by granulation tissue formation.

Rate of of wound infection15 days, 1 and 3 month after surgery

Rate of of wound infection, revealed by physical examination

score of pre and postoperative painbaseline, discharge, 15 days 1 and 3 month after surgery

pain measured by the visual analogue scale or visual analog scale (VAS) questionnaire

Concentration of serum IGF-1baseline, 1 month after surgery

Concentration of Insulin-like growth factor-1

Concentration of serum albuminbaseline, 1 month after surgery

Concentration of serum albumin

Concentration of serum total proteinbaseline, 1 month after surgery

Concentration of serum total protein

Concentration of serum hsCRPbaseline, 48 hour,15 days and 1 month after the surgery

Concentration of serum high-sensitivity C-reactive protein

Trial Locations

Locations (1)

Zahra vahdat shariatpanahi

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath